CClinicalTrials.gg
CompletedNCT03296748Updated Oct 24, 2017

Correction of Asymptomatic 2nd Degree Cystocele in Patient With Stress Incontinence

A Phase 2/3 interventional study of trans-obturator tape inside-out usingsoft tapes. and anterior colporraphy in Stress Urinary Incontinence, sponsored by Kasr El Aini Hospital. Completed at 1 site in Egypt. Open to female participants aged 23 Years to 56 Years. Per ClinicalTrials.gov, last updated 2017-10-24.

Sponsored by Kasr El Aini Hospital · Phase 2/3, Interventional, and Treatment

Phase
Phase 2/3
Study type
Interventional
Enrollment
123
Allocation
Non-randomized
Ages
23 Years to 56 Years
Sex
Female
01

Study summary

The aim of our study is to assess the value of concomitant surgical correction of asymptomatic grade II anterior vaginal wall prolapse with the placement of midurethral sling for treatment of female patients with stress incontinence

Read the detailed description

female patients with stress urinary incontinence and asymptomatic grade II anterior vaginal wall prolapse were divided into Group A: treated only with trans-obturator tape (TOT) and group B where' TOT was associated with anterior colporrhaphy and the outcome is compared.

02

Conditions studied

  • Stress Urinary Incontinence

Keywords

  • asymptomatic cystocele.
  • stress urinary incontinence
03

Who can participate

Ages eligible
23 Years to 56 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • female patients
  • genuine stress incontinence

    • asymptomatic cystocele

Exclusion criteria

Exclusion Criteria:

  • mixed incontinence
04

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
123 participants (actual)

Study arms

  • Active comparator
    TOT only group

    60 patients with stress incontinence and asymptomatic grade 2 cystocele.

    Procedure: trans-obturator tape inside-out usingsoft tapes.

  • Active comparator
    concomitant repair group

    63 patients with stress incontinence and asymptomatic grade 2 cystocele.

    Procedure: trans-obturator tape inside-out usingsoft tapes. · Procedure: anterior colporraphy

Interventions

  • Proceduretrans-obturator tape inside-out usingsoft tapes.

    trans-obturator tape inside-out soft tapes is applied under spinal anesthesia. After the procedure, the vaginal gauze packing and Foley catheter were removed on the morning of the next day.

    Also known as: anterior colporrhaphy

  • Procedureanterior colporraphy
05

What researchers measure

Primary outcomes

  1. cure rate of stress incontinence

    by clinical assessment

    Time frame: 3 months after surgery

  2. Denovo urgency

    by clinical assessment

    Time frame: 3 months after surgery

Secondary outcomes

  1. cure rate of stress incontinence

    by clinical assessment

    Time frame: 6 months after surgery

  2. cure rate of stress incontinence

    by clinical assessment

    Time frame: 12 months after surgery

  3. Denovo urgency

    by clinical assessment

    Time frame: 6 months after surgery

  4. Denovo urgency

    by clinical assessment

    Time frame: 12 months after surgery

06

Study locations

1 site
  • Kasr El Ainiy Hospital
    Cairo, 11562, Egypt
07

Registry details

Key details

Study ID
NCT03296748
Lead sponsor
Kasr El Aini Hospital
Responsible party
sarah mohamed hassan (lecturer of obstetrics and gynecology Cairo university, Kasr El Aini Hospital) — Principal investigator
First posted
Sep 28, 2017
Start date
Jun 1, 2016
Primary completion
Sep 2017
Completion
Sep 2017
Last update
Oct 24, 2017

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion